Stay updated on PH94B Safety in Social Anxiety Disorder Clinical Trial
Sign up to get notified when there's something new on the PH94B Safety in Social Anxiety Disorder Clinical Trial page.

Latest updates to the PH94B Safety in Social Anxiety Disorder Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 3 trial for PH94B in treating Social Anxiety Disorder, while retaining the mention of the drug and its revision number.SummaryDifference36%
- Check17 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check60 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check75 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check82 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check96 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
Stay in the know with updates to PH94B Safety in Social Anxiety Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Safety in Social Anxiety Disorder Clinical Trial page.